Live feed
Filing
SC 13D/A
SC 13D/A0001140361-14-022049·Lineage Cell Therapeutics, Inc.
Schedule 13D ownership disclosure
BIOTIME INC
Security class unavailable · CUSIP: 09066L105
Event date: 2014-05-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,627,405
- Percent of class
- 2.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-14-022049
- Form type
- SC 13D/A
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- May 19, 2014
- Reporting period
- May 16, 2014
- Description
- Schedule 13D beneficial ownership